Moeda Consulting Corp.

From concept to
executable program.

Scientific and strategic leadership for early-stage biotech, from proof-of-concept to IND-enabling.

Get in touch
Decide, Develop, Advance — the Moeda program journey

What We Do

Embedded scientific and strategic leadership.

01

Ideation and Diligence

Scientific, translational, and commercial due diligence of assets and IP, including spinout positioning, clinical path framing, and investor readiness. Determines whether there is a real product and whether it is worth building.

02

Derisking and Execution

Design and execution of go/no-go strategies, including in vitro and in vivo validation, PK/PD planning, and data packages aligned with IND-enabling expectations. Evidence that supports confident decision-making.

03

Scientific Leadership

Fractional scientific leadership across preclinical strategy, CMC and manufacturability considerations, and investor-facing data package development for fundraising milestones.

About

Dr. Moe Wehbe
Moe Wehbe, Ph.D.
Founder, Moeda Consulting Corp.

Moe Wehbe is a pharmaceutical scientist and drug delivery platform builder with more than a decade of experience developing and translating therapeutic delivery technologies. He earned his Ph.D. in Pharmaceutical Sciences from the University of British Columbia, where his doctoral research focused on lipid-based drug delivery and led to the co-invention of a metal-complexed liposomal technology.

He completed postdoctoral training at Vanderbilt University focused on polymeric drug delivery and immuno-engineering.

Moe later joined ReCode Therapeutics, where he worked on LNP formulation, scale-up, and translational development supporting rodent and NHP programs, as well as technology transfer to external manufacturing partners. He then became a founding scientist at Mirai Bio within the Flagship Pioneering ecosystem, helping build and optimize extrahepatic delivery systems for in vivo cell engineering and tissue-selective genetic medicines.

Moe founded Moeda Consulting Corp. to bring that combination of scientific depth, platform-building experience, and translational judgment to biotechnology companies, founders, investors, and academic teams.

15+
Years in drug delivery
& translational science
25+
Peer-reviewed
publications
Founding scientist

What clients say

Built on real programs.

Start with a conversation.

No slides required. 30 minutes. Brief on the program or question, and we will tell you if there is a fit.